Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis
NCT ID: NCT04989114
Last Updated: 2021-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
96 participants
INTERVENTIONAL
2020-09-06
2021-09-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Controlled Trial Comparing Standard Versus Positive Pressure Nebulization in Infants With Bronchiolitis to Reduce Hospital Admissions
NCT01229384
Chest Pressure for Intubated Peds Patients
NCT02615834
Effect of Bubble Positive Expiratory Pressure and Segmental Breathing Versus Incentive Spirometry in Pleural Effusion
NCT07248774
Efficacy of Nebulised Hypertonic Saline (3%) Among Children With Bronchiolitis.
NCT01276821
High Flow Nasal Oxygen Therapy in Pediatric Hypercapnic Respiratory Failure During Perioperative Stage
NCT03534960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard care
In this arm, oxygen inhalation will be provided without positive end expiratory pressure
No interventions assigned to this group
nasal continuous positive airway pressure
In this arm, positive end expiratory pressure will be provided by nasal continuous positive airway pressure
nasal continuous positive airway pressure
positive end expiratory pressure will be applied by nasal continuous positive airway pressure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nasal continuous positive airway pressure
positive end expiratory pressure will be applied by nasal continuous positive airway pressure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients whose caretakers refuse written informed consent
* Patients having consolidation on chest X-Ray
2 Months
2 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Edward Medical University
OTHER
ameer asadullah gull
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ameer asadullah gull
Postgraduate Resident Pediatric Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muhammad Haroon Hamid, MBBSFCPSFRCS
Role: PRINCIPAL_INVESTIGATOR
King Edward Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Hospital
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
704/RC/KEMU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.